title: Parvalbumin interneurons and calretinin fibers arising from the thalamic nucleus reuniens degenerate in the subiculum after kainic acid-induced seizures.
abstract: The subiculum is the major output area of the hippocampus. It is closely interconnected with the entorhinal cortex and other parahippocampal areas. In animal models of temporal lobe epilepsy (TLE) and in TLE patients it exerts increased network excitability and may crucially contribute to the propagation of limbic seizures. Using immunohistochemistry and in situ-hybridization we now investigated neuropathological changes affecting parvalbumin and calretinin containing neurons in the subiculum and other parahippocampal areas after kainic acid-induced status epilepticus. We observed prominent losses in parvalbumin containing interneurons in the subiculum and entorhinal cortex, and in the principal cell layers of the pre- and parasubiculum. Degeneration of parvalbumin-positive neurons was associated with significant precipitation of parvalbumin-immunoreactive debris 24 h after kainic acid injection. In the subiculum the superficial portion of the pyramidal cell layer was more severely affected than its deep part. In the entorhinal cortex, the deep layers were more severely affected than the superficial ones. The decrease in number of parvalbumin-positive neurons in the subiculum and entorhinal cortex correlated with the number of spontaneous seizures subsequently experienced by the rats. The loss of parvalbumin neurons thus may contribute to the development of spontaneous seizures. On the other hand, surviving parvalbumin neurons revealed markedly increased expression of parvalbumin mRNA notably in the pyramidal cell layer of the subiculum and in all layers of the entorhinal cortex. This indicates increased activity of these neurons aiming to compensate for the partial loss of this functionally important neuron population. Furthermore, calretinin-positive fibers terminating in the molecular layer of the subiculum, in sector CA1 of the hippocampus proper and in the entorhinal cortex degenerated together with their presumed perikarya in the thalamic nucleus reuniens. In addition, a significant loss of calretinin containing interneurons was observed in the subiculum. Notably, the loss in parvalbumin positive neurons in the subiculum equaled that in human TLE. It may result in marked impairment of feed-forward inhibition of the temporo-ammonic pathway and may significantly contribute to epileptogenesis. Similarly, the loss of calretinin-positive fiber tracts originating from the nucleus reuniens thalami significantly contributes to the rearrangement of neuronal circuitries in the subiculum and entorhinal cortex during epileptogenesis.
authors: Department of Pharmacology, Innsbruck Medical University, Peter-Mayr-Str. 1a, 6020 Innsbruck, Austria. meinrad.drexel@i-med.ac.at
authors: M
authors: M
authors: Drexel
authors: A P
authors: AP
authors: Preidt
authors: E
authors: E
authors: Kirchmair
authors: G
authors: G
authors: Sperk
references: Neuroscientist. 2001 Aug;7(4):340-52
references: 11488399
references: Neuroscience. 2008 Oct 15;156(3):653-61
references: 18789377
references: J Neurosci. 2001 Aug 1;21(15):5804-12
references: 11466452
references: Science. 2002 Nov 15;298(5597):1418-21
references: 12434059
references: Neuroscience. 2001;108(4):587-600
references: 11738496
references: Brain. 2009 Nov;132(Pt 11):3032-46
references: 19767413
references: Brain Res. 1997 Jun 20;760(1-2):109-17
references: 9237525
references: J Neurosci. 1997 Jul 15;17(14):5640-50
references: 9204945
references: Acta Neuropathol. 1994;87(2):187-95
references: 8171969
references: J Comp Neurol. 1991 Jun 15;308(3):381-96
references: 1865007
references: J Neurosci. 1988 Jun;8(6):2123-30
references: 3385490
references: Neuroscience. 1983 Dec;10(4):1301-15
references: 6141539
references: Neurosci Lett. 1993 May 28;155(1):1-6
references: 8361655
references: Hippocampus. 2001;11(4):452-68
references: 11530850
references: Hippocampus. 2004;14(2):193-215
references: 15098725
references: Neuroscience. 2007 Oct 12;149(1):131-43
references: 17850980
references: J Comp Neurol. 2008 Jan 10;506(2):359-70
references: 18022947
references: Neuroscience. 1992;48(1):1-27
references: 1584417
references: Epilepsia. 2001 Aug;42(8):967-78
references: 11554881
references: J Neurosci. 2003 Sep 17;23(24):8471-9
references: 13679415
references: Neuroscience. 2005;136(3):729-39
references: 16344147
references: Exp Brain Res. 1988;72(2):347-62
references: 3066634
references: J Neuropathol Exp Neurol. 1997 Sep;56(9):988-98
references: 9291940
references: Hippocampus. 1996;6(3):239-46
references: 8841824
references: Brain. 2010 Sep;133(9):2763-77
references: 20576695
references: J Comp Neurol. 2005 Mar 21;483(4):476-88
references: 15700275
references: Eur J Neurosci. 2002 Oct;16(7):1227-39
references: 12405983
references: J Comp Neurol. 1990 Jun 8;296(2):179-203
references: 2358531
references: Hippocampus. 2006;16(10):843-60
references: 16897722
references: Acta Neuropathol. 2000 May;99(5):547-54
references: 10805100
references: J Comp Neurol. 1997 Feb 17;378(3):363-78
references: 9034897
references: Prog Neurobiol. 1994 Jan;42(1):1-32
references: 7480784
references: Exp Brain Res. 1991;85(1):129-36
references: 1884753
references: Brain. 2005 Jan;128(Pt 1):138-52
references: 15548550
references: Epilepsia. 2005;46 Suppl 5:17-21
references: 15987248
references: Nature. 2003 Feb 20;421(6925):844-8
references: 12594513
references: Biochemistry. 1991 Jan 22;30(3):656-62
references: 1988053
references: Brain. 2008 Jun;131(Pt 6):1516-27
references: 18504292
references: Neurosci Lett. 2000 Jan 14;278(3):145-8
references: 10653014
references: Eur J Neurosci. 2009 Aug;30(4):611-24
references: 19674083
references: Eur J Biochem. 1982 Oct;127(2):381-9
references: 6754379
references: Neurobiol Dis. 2005 Aug;19(3):451-60
references: 16023587
references: Epilepsia. 1984 Dec;25(6):729-40
references: 6510381
references: Electroencephalogr Clin Neurophysiol. 1982 Jun;53(6):581-9
references: 6177503
references: Brain Res. 1980 Jun 2;191(1):79-97
references: 7378761
references: Exp Neurol. 2004 Jun;187(2):367-79
references: 15144863
references: Lancet Neurol. 2004 Jul;3(7):421-30
references: 15207799
references: Neuroscience. 1993 Sep;56(2):317-35
references: 8247263
references: J Physiol. 2005 Jan 1;562(Pt 1):9-26
references: 15539390
references: J Comp Neurol. 2003 May 12;459(4):407-25
references: 12687707
references: J Neurosci. 1996 May 15;16(10):3397-411
references: 8627375
references: Eur J Neurosci. 2004 Mar;19(5):1243-56
references: 15016082
references: Epilepsy Res. 2002 Jun;50(1-2):93-103
references: 12151121
references: Neuron. 1996 Apr;16(4):815-23
references: 8607999
references: Neuroscience. 1997 Oct;80(4):1019-32
references: 9284057
references: Neuroscience. 1999;92(1):15-26
references: 10392827
references: J Neurosci. 1999 Nov 15;19(22):10082-97
references: 10559416
references: J Comp Neurol. 1989 Feb 8;280(2):183-96
references: 2925892
references: J Neurophysiol. 1992 Jul;68(1):1-8
references: 1355524
references: J Physiol. 2008 Apr 1;586(7):1867-83
references: 18238812
references: Hippocampus. 1995;5(2):141-6
references: 7633517